2St-Germain ME, Gagnon V, Parent S, et al. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway [J]. MolCancer, 2004, 11 (3) :7.
3Fujuwaki R, Iida K, Kanasaki H, et al. Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase [J]. Hum pathoj, 2002, 33 ( 2 ) :213-219.
4Cao QJ, Einstein MH, Anderson PS, et al. Expression of COX-2, Ki-67, eyelin D1, and p21 in endometrial endometrioid carcinomas [J]. Int J Gyneeol Pathol, 2002,21(2):147-154.
5Li W, Xu RJ, Jiang LH, et al. Expression of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase Correlates with Tumor Angiogenesis in Endometrial Carcinoma [J]. Med Oncol,2005, 22(1) : 63-70.
6Konerding MA, Fait E, Dimitropoulou C, et al. Impact of fihrohlast growth factor-2 on tumor microvascular architecture.A tridimensional morphometric study[J]. Am J Pathol, 1998,152: 1607-1616.
7Toyoki H, Fujimoto J, Sato E, et al. Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancers [J]. Ann Oncol,2005,16(1) : 51-55.
8Kokawa K, Shikone T,et al. Apoptosis and the expression of bel-2 and Bax in patients with endometrioid clear cell, and serous carcinoma of the uterine endometrium [J]. Cynecol oncol, 2001, 81(2): 178-183.
10Akhtar M, Cheng Y, Magno RM, et al. Promoter methlation regulates Helicohacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells [J]. cancer Res, 2001,61(6) : 2399-2403.
二级参考文献25
1连利娟 主编.林巧稚妇科肿瘤学.第2版[M].北京:人民卫生出版社,1994.390-398.
2[1]Leahy KM, Ornberg PL, Wang H. Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endoyhelial cells in vivo[J]. Cancer Res, 2002,62(3):625-631.
3[2]Nogawa S, Forster C, Zhang F, et al. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia[J]. Proc Natl Acad Sci USA, 1998, 95(18):10966-10971.
4[3]Merati K, Siadaty MS, Andea A, et al. Epression of inflammatory modulator COX-2 in pancreatic ductal adenocarcinoma and its relationship to pathologic and clinical parameters[J]. Am J Clin Oncol, 2001, 24:(5) 447-452.
5[4]Tucker ON, Dannenberg AJ, Yang EK,et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer[J]. Cancer Res, 1999,59(5):987-990 .
6[5]Ferrandina G, Legge F, Ranelletti FO, et al. Cyclooxygenase-2 expression in endometrial carcinoma:correlation with clinicopathologic parameters and clinical outcome[J]. Cancer, 2002, 95(4):801-807.
7[6]Soslow RA, Dannenberg AJ, Rush D, et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors[J]. Cancer, 2000, 89(12):2637-2645.
8[7]Ambs S, Merriam WG, Bennett WP, et al. Frequent nitric oxide synthease-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression[J]. Cancer Res, 1998, 58(2):334-341.
9[8]Hamaoka R, Yaginuma Y, Takahashi T, et al. Different expression patterns of nitric oxide synthase isozymes in various gynecological cancers[J]. J cancer Res Clin Oncol, 1999, 125(6):321-326.
10[9]Chin K, Kurashima Y, Ogura T, et al. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells[J]. Oncogene, 1997, 15(4): 437-442.
